AcuFocus's Kamra presbyopia implant gets mixed panel review
This article was originally published in Clinica
Executive Summary
US FDA approval of AcuFocus’s first-of-a-kind Kamra inlay intra-corneal implant hangs in the balance after a mixed review from an advisory panel. The device is used to treat presbyopia, when the ageing eye loses its ability to focus on near objects.